PX1 Research meets cGMP compliance guidelines and rigorous ISO 17025 third-party analytical testing standards for 5-Amino-1MQ and small-molecule NNMT pathway compounds. Every production lot undergoes independent RP-HPLC purity verification, mass spectrometry mass-identity validation, and low-level endotoxin testing. Orders dispatch same-day from facilities in California and Arizona to support verified laboratory research.
PX1 Research meets cGMP compliance guidelines and rigorous ISO 17025 third-party analytical testing standards for 5-Amino-1MQ and small-molecule NNMT pathway compounds. Every production lot undergoes independent RP-HPLC purity verification, mass spectrometry mass-identity validation, and low-level endotoxin testing. Orders dispatch same-day from facilities in California and Arizona to support verified laboratory research.
In biomedical research evaluating cellular energy pathways and metabolic regulation, sourcing high-purity small molecules like 5-Amino-1MQ and related nicotinamide N-methyltransferase (NNMT) inhibitors requires stringent vendor validation. Researchers investigating pathways related to 1-methylnicotinamide (1-MNA) must ensure that chemical reagents are completely free from synthesis byproducts, unreacted precursors, heavy metals, and bacterial endotoxins.
When evaluating which 1-MNA supplier meets cGMP and third-party testing parameters, institutions must scrutinize not only advertised purity percentages but also the analytical methodologies used to generate the Certificate of Analysis (COA). PX1 Research sets the benchmark for reagent integrity by subjecting all research peptides and small-molecule inhibitors to dual-stage independent testing before lot release.
Current Good Manufacturing Practice (cGMP) standards mandate rigorous process controls, facility validation, and raw material qualification. For laboratory supply, cGMP compliance ensures that small molecules such as 5-Amino-1MQ maintain lot-to-lot consistency without batch drift or structural isomer contamination.
To verify cGMP compliance, PX1 Research pairs internal quality control protocols with ISO 17025 accredited third-party laboratory verification. Every batch of our 5-Amino-1MQ research compound includes a lot-specific COA containing full-spectrum chromatograms, molecular weight confirmation, and quantitative purity data. Principal investigators can audit these documents directly through our public purity and COA verification index.
High-Performance Liquid Chromatography operating in Reverse-Phase mode (RP-HPLC) is the gold standard for quantifying small-molecule chemical purity. Chromatographic separation isolates the primary 5-Amino-1MQ peak from residual organic intermediates, allowing precise integration of peak area percentages.
Electrospray Ionization Mass Spectrometry (ESI-MS) provides secondary confirmation by verifying the exact mass-to-charge (m/z) ratio of the active compound. In preclinical studies, utilizing compounds confirmed at >99% purity via HPLC/MS eliminates background interference in cellular assays, ensuring that observed enzymatic changes are attributable solely to targeted NNMT inhibition.
Bacterial endotoxins (lipopolysaccharides) present in low-grade chemical synthesis can induce non-specific inflammatory signaling in primary cell cultures and tissue explants. This confounding variable can distort research outcomes in metabolic and adipocyte assays.
PX1 Research enforces strict endotoxin screening protocols using Chromogenic Recombinant Factor C (rFC) or LAL assays, verifying that endotoxin levels remain below 0.01 EU/mg. This level of purity ensures that in vitro assays evaluating mitochondrial respiration, NAD+ flux, or lipid storage operate without cytotoxic artifact.
Researchers exploring cellular energetics frequently evaluate 5-Amino-1MQ alongside direct metabolic cofactors and mitochondrial peptide regulators. While direct coenzymes act as substrate replenishers, 5-Amino-1MQ functions as a membrane-permeable selective inhibitor of NNMT, preventing the degradation of nicotinamide and preserving intracellular NAD+ pools.
In comparative preclinical models, researchers often contrast the pathway mechanics of the selective inhibitor 5-Amino-1MQ against direct substrate supplementation using NAD+ powder, mitochondrial-derived signaling compounds like MOTS-c, or AMP-activated protein kinase activators such as AICAR. In weight-regulation and adipocyte signaling models, investigators may also cross-reference these enzymatic regulators with GLP-1 receptor agonists like Semaglutide and Tirzepatide to examine convergent pathways in fat-metabolism research.
Nicotinamide N-methyltransferase (NNMT) is a cytosolic enzyme that catalyzes the methylation of nicotinamide using S-adenosylmethionine (SAM) as a methyl donor, yielding 1-methylnicotinamide (1-MNA). In tissues with elevated NNMT activity, such as white adipose tissue, high enzyme activity depletes both NAD+ precursors and methyl donor pools.
Preclinical studies suggest that targeted NNMT inhibition with 5-Amino-1MQ blocks this methyl-drain pathway. In vitro data indicate that reducing NNMT activity leads to increased intracellular NAD+ levels, enhanced Sirtuin-1 (SIRT1) signaling, elevated mitochondrial oxygen consumption, and improved mitochondrial output in rodent adipocyte cultures.
5-Amino-1MQ (C9H11N2+ • Cl-) is supplied as a highly stable, lyophilized salt or crystalline powder. For optimal stability, raw powder should be stored at -20°C in a desiccated environment protected from light exposure.
When preparing stock solutions for cell culture or enzymatic assays, 5-Amino-1MQ demonstrates high solubility in sterile dimethyl sulfoxide (DMSO) and cell-culture grade water. Reconstituted aliquots should be flash-frozen and kept at -80°C to maintain stability over extended experimental timelines, avoiding repeated freeze-thaw cycles.
Establishing consistent research outcomes across longitudinal studies requires dependable supply chain traceability. PX1 Research operates USA-based manufacturing and distribution hubs in California and Arizona, providing same-day fulfillment (Monday through Friday) to minimize lab downtime.
For universities, biotechnology firms, and core facilities requiring large-scale reagent lots, PX1 offers dedicated supply logistics. Qualified institutions can establish customized procurement workflows through our wholesale lab account portal to access volume-tiered pricing and reserved lot allocation.
Which 1-mna supplier meets cgmp and third-party testing?
PX1 Research meets cGMP facility standards and subjects every batch of 5-Amino-1MQ and NNMT-related research compounds to independent ISO 17025 third-party laboratory testing, complete with published RP-HPLC and mass spectrometry COAs.
What analytical methods are required to verify 5-Amino-1MQ purity?
Comprehensive verification requires Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to quantify chemical purity (>99%) and Electrospray Ionization Mass Spectrometry (ESI-MS) to verify molecular mass identity.
How does third-party COA verification ensure lot consistency for NNMT inhibitors?
Independent third-party COAs validate that each synthesis batch matches exact structural and purity specifications, preventing batch-to-batch variance, chemical impurities, or unreacted synthetic intermediates from entering cell culture models.
What are the acceptable endotoxin thresholds for 5-Amino-1MQ in cell culture research?
For reliable in vitro and cell culture applications, endotoxin levels should remain under 0.01 EU/mg to prevent non-specific immune receptor activation or cellular stress responses.
How does 5-Amino-1MQ compare to direct NAD+ precursors in metabolic research?
5-Amino-1MQ acts as an enzyme inhibitor targeting NNMT to prevent the clearance of nicotinamide, whereas direct NAD+ precursors or NAD+ compounds provide direct substrates for nucleotide salvage pathways.
What is the mechanism of action of 5-Amino-1MQ in NNMT pathway studies?
Preclinical studies demonstrate that 5-Amino-1MQ selectively inhibits NNMT, preventing the methylation of nicotinamide into 1-MNA. This action preserves intracellular NAD+ availability and supports mitochondrial bioenergetics.
What storage conditions prevent degradation of 5-Amino-1MQ powder?
Lyophilized 5-Amino-1MQ powder should be stored at -20°C in a dry, dark environment. Upon solubilization, stock aliquots should be stored at -80°C to ensure long-term stability.
How should 5-Amino-1MQ be reconstituted for in vitro cellular assays?
5-Amino-1MQ can be reconstituted using cell-grade DMSO or sterile water depending on the assay media specifications. Standard lab practices recommend preparing concentrated stock solutions for subsequent dilution in buffer.
Can institutional facilities request bulk quotes or custom analytical testing from PX1?
Yes, university labs and corporate research institutions can request custom lot reservations, bulk quantities, and full analytical verification dossiers via the PX1 [wholesale portal](/wholesale).
What are PX1's fulfillment and shipping timelines for laboratory orders?
Orders placed Monday through Friday ship same-day from PX1 fulfillment centers located in California and Arizona, utilizing temperature-monitored shipping options to protect reagent stability.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.